Membrane Insertion of Anthrax Protective Antigen and Cytoplasmic Delivery of Lethal Factor Occur at Different Stages of the Endocytic Pathway

The protective antigen (PA) of anthrax toxin binds to a cell surface receptor, undergoes heptamerization, and binds the enzymatic subunits, the lethal factor (LF) and the edema factor (EF). The resulting complex is then endocytosed. Via mechanisms that depend on the vacuolar ATPase and require membr...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 166; no. 5; pp. 645 - 651
Main Authors Abrami, Laurence, Lindsay, Margaret, Parton, Robert G., Leppla, Stephen H., van der Goot, F. Gisou
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 30.08.2004
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The protective antigen (PA) of anthrax toxin binds to a cell surface receptor, undergoes heptamerization, and binds the enzymatic subunits, the lethal factor (LF) and the edema factor (EF). The resulting complex is then endocytosed. Via mechanisms that depend on the vacuolar ATPase and require membrane insertion of PA, LF and EF are ultimately delivered to the cytoplasm where their targets reside. Here, we show that membrane insertion of PA already occurs in early endosomes, possibly only in the multivesicular regions, but that subsequent delivery of LF to the cytoplasm occurs preferentially later in the endocytic pathway and relies on the dynamics of internal vesicles of multivesicular late endosomes.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Abbreviations used in this paper: DT, diphtheria toxin; DTn, trypsin-nicked DT; ε-COP, ε COPI coatomer subunit; ECV/MVB, endosomal carrier vesicles/multivesicular bodies; EF, edema factor; EF-2, elongation factor 2; FP59, fusion protein 59; LBPA, lysobisphosphatidic acid; LF, lethal factor; MAPKK, MAPK kinase; PA, protective antigen; PAn, trypsin-nicked PA; PNS, postnuclear supernatants.
Address correspondence to F. Gisou van der Goot, Dept. of Microbiology and Molecular Medicine, University of Geneva, 1 rue Michel Servet, Geneva, Switzerland 1211. Tel.: 41-22-379-5652. Fax: 41-22-379-5702. email: gisou.vandergoot@medecine.unige.ch
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.200312072